1. Home
  2. ELTX vs VTSI Comparison

ELTX vs VTSI Comparison

Compare ELTX & VTSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Elicio Therapeutics Inc.

ELTX

Elicio Therapeutics Inc.

HOLD

Current Price

$2.18

Market Cap

63.3M

Sector

Health Care

ML Signal

HOLD

Logo VirTra Inc.

VTSI

VirTra Inc.

HOLD

Current Price

$2.92

Market Cap

51.0M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ELTX
VTSI
Founded
2011
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Miscellaneous manufacturing industries
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
63.3M
51.0M
IPO Year
2014
1999

Fundamental Metrics

Financial Performance
Metric
ELTX
VTSI
Price
$2.18
$2.92
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
1
Target Price
$18.00
$5.00
AVG Volume (30 Days)
266.2K
33.8K
Earning Date
05-12-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
39.29
N/A
EPS
N/A
N/A
Revenue
$2,301,000.00
$185,971.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$27.30
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.34
$2.88
52 Week High
$16.00
$6.29

Technical Indicators

Market Signals
Indicator
ELTX
VTSI
Relative Strength Index (RSI) 24.01 41.98
Support Level N/A N/A
Resistance Level $3.32 $3.59
Average True Range (ATR) 0.13 0.12
MACD -0.03 -0.01
Stochastic Oscillator 1.09 7.92

Price Performance

Historical Comparison
ELTX
VTSI

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company advancing novel immunotherapies for the treatment of cancer, including mKRAS-positive pancreatic cancer, colorectal cancer (CRC), lung cancer, and other mKRAS-positive cancers. The Company focuses on developing effective, off-the-shelf immunotherapies using its proprietary Amphiphile (AMP) technology, which aims to enhance the education, activation, and amplification of cancer-specific T cells to promote durable cancer immunosurveillance. Its clinical pipeline includes ELI-002 7P, a lymph node-targeted cancer immunotherapy currently being evaluated in a Phase 2 study for mKRAS pancreatic ductal adenocarcinoma (PDAC), a common form of pancreatic cancer.

About VTSI VirTra Inc.

VirTra Inc is a U.S.-based company that is engaged in the sale and development of judgmental use-of-force training simulators and firearms training simulators for law enforcement, military, and commercial uses. It sells simulators and related products across the globe through a direct sales force and international distribution partners. The services provided by the company include installation, training, limited warranties, service agreements, and related support. The company operates in six segments, which include Simulators and Accessories, Extended Service, Customized software and Custom content, Installation and Training, Design and Prototyping, and Subscription Training Equipment Partnership. The majority of its revenue is generated from the Simulators and Accessories segment.

Share on Social Networks: